BOP1 confers chemoresistance of triple‐negative breast cancer by promoting CBP ‐mediated β‐catenin acetylation

LIN9 and NEK2 are core regulators of mitotic fidelity that can be therapeutically targeted to overcome taxane resistance

(2020) Melyssa S Roberts et al.   CANCER RESEARCH

Block of proliferation 1 promotes cell migration and invasion in human colorectal cancer cells via the JNK pathway

(2020) Xiaoxi Chen et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Chromosome 12p Amplification in Triple-Negative/BRCA1-Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin Sensitivity

(2019) Jorge Gómez-Miragaya et al.   CANCER RESEARCH

TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway

(2019) Weiguang Liu et al.   Frontiers in Oncology

CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer

(2019) Lei Nie et al.   Nature Communications

Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors

(2018) Nithya Krishnamurthy et al.   CANCER TREATMENT REVIEWS

Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome

(2018) Brian T. Weinert et al.   CELL

Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer

(2018) Abhishek Gangrade et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling

(2018) Geyan Wu et al.   CLINICAL CANCER RESEARCH

CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer

(2018) Alexander Ring et al.   Cancers

NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit

(2017) Wei Wang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling

(2017) Peng Han et al.   Molecular Cancer

Trimethylation and Acetylation of β-Catenin at Lysine 49 Represent Key Elements in ESC Pluripotency

(2017) Katrin Hoffmeyer et al.   Cell Reports

RECQL4 helicase has oncogenic potential in sporadic breast cancers

(2016) Arvind Arora et al.   JOURNAL OF PATHOLOGY

Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway

(2016) Z-M Zhang et al.   ONCOGENE

Aldehyde Dehydrogenase Is Regulated by  -Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells

(2015) M. Cojoc et al.   CANCER RESEARCH

Activated Thyroid Hormone Promotes Differentiation and Chemotherapeutic Sensitization of Colorectal Cancer Stem Cells by Regulating Wnt and BMP4 Signaling

(2015) V. Catalano et al.   CANCER RESEARCH

New Wnt/β-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals

(2015) Jingjing Qi et al.   GUT

Molecularly targeted therapies for metastatic triple-negative breast cancer

(2013) Soley Bayraktar et al.   BREAST CANCER RESEARCH AND TREATMENT

SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β-catenin

(2013) Petra Simic et al.   EMBO Molecular Medicine

The Wnt/β-catenin pathway in ovarian cancer: A review

(2013) Rebecca C. Arend et al.   GYNECOLOGIC ONCOLOGY

Neoadjuvant treatments for triple-negative breast cancer (TNBC)

(2012) G. von Minckwitz et al.   ANNALS OF ONCOLOGY

Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients

(2011) Felipe de Sousa E Melo et al.   Cell Stem Cell

Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition

(2011) Kit-Ying Chung et al.   HEPATOLOGY

Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

(2010) Sunil Badve et al.   MODERN PATHOLOGY

Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases

(2009) Bryan T. MacDonald et al.   DEVELOPMENTAL CELL

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

(2009) C. J. Creighton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis

(2008) Mads Thomassen et al.   BREAST CANCER RESEARCH AND TREATMENT

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

(2008) Cornelia Liedtke et al.   JOURNAL OF CLINICAL ONCOLOGY